Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype

2Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dent disease type 1 is suspected in the presence of a complete phenotype of low molecular weight (LMW) proteinuria, hypercalciuria and at least one of the following: nephrocalcinosis, nephrolithiasis, haematuria, hypophosphatemia or chronic kidney disease (CKD). We present two brothers who presented with CKD alone. In the absence of typical clinical features, further assessment of LMW proteinuria and hypercalciuria was not undertaken. Whole-genome sequencing revealed hemizygous loss of function mutations in chloride voltage-gated channel 5 (CLCN5) consistent with Dent disease. Dent disease should, therefore, be considered in patients with an incomplete phenotype, including unexplained CKD alone.

Cite

CITATION STYLE

APA

Leggatt, G., Gast, C., Gilbert, R. D., Veighey, K., Rahman, T., & Ennis, S. (2023). Hemizygous loss of function mutations in CLCN5 causing end-stage kidney disease without Dent disease phenotype. Clinical Kidney Journal, 16(1), 192–194. https://doi.org/10.1093/ckj/sfac127

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free